Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study.

Source:http://linkedlifedata.com/resource/pubmed/id/19107385

Download in:

View as

General Info

PMID
19107385